Soleno Therapeutics Inc (SLNO)
37.11
-0.79
(-2.08%)
USD |
NASDAQ |
Apr 18, 16:00
37.13
+0.02
(+0.05%)
After-Hours: 20:00
Soleno Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2014 | -0.0091 |
| September 30, 2014 | -0.3682 |
| June 30, 2014 | -0.3701 |
| March 31, 2014 | -0.3717 |
| December 31, 2013 | -0.3695 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cassava Sciences Inc | -- |
| ImmunityBio Inc | -1.161 |
| Avid Bioservices Inc | 0.7685 |
| United Therapeutics Corp | 0.117 |
| Creative Medical Technology Holdings Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 180.69M |
| Total Liabilities (Quarterly) | 23.18M |
| Shareholders Equity (Quarterly) | 157.51M |